Filing is supported by strong clinical data and IND enabling pre-clinical data associated withTCB-008 in treatment of Acute Myeloid Leukemia The IND application leverages pioneering research on the ...

ENGLEWOOD, Colo., March 19, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI" or the "Company"), a pioneer in VTOL and powered-lift aircraft solutions, today announced that its Type ...

(RTTNews) - TC BioPharm (Holdings) Plc. (TCBP) Monday announced that the FDA provided clearance on an investigational new drug application for a Phase 1B study in relapse/refractory Acute Myeloid ...